Articles for Icmr Study

COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India: ICMR study
1 year, 1 month ago

COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India: ICMR study

Live Mint  

COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, says ICMR study. COVID-19 vaccination did not increase the risk of sudden deaths among young adults in India, according to a study conducted by the Indian Council of Medical Research. {{^adFree}} {{/adFree}} "COVID-19 vaccination did not increase the risk of sudden deaths among young …

India Death Vaccination Deaths Young Covid Study
Pre-Covid shots provided 60% protection against post-infection deaths: Study
1 year, 4 months ago

Pre-Covid shots provided 60% protection against post-infection deaths: Study

India Today  

The Indian Council of Medical Research, which studied the cause of death in people after recovering from Covid-19 infection, found that those who were vaccinated before contracting the virus had 60 per cent protection against post-discharge mortality. An expert team working at the National Clinical Registry for Covid evaluated factors related to post-discharge mortality during the first year after Covid, …

Discharge Covid One Year Icmr Study
Omicron variant of SARS-CoV-2 can evade immunity provided by vaccines: ICMR study
2 years, 1 month ago

Omicron variant of SARS-CoV-2 can evade immunity provided by vaccines: ICMR study

The Hindu  

Omicron, a variant of SARS-CoV-2, can evade immunity provided by vaccines, states a new study published by the Indian Council of Medical Research. Titled ‘Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India’, the study was published on November 2 in Frontiers in Medicine, a peer-reviewed open access medical …

India Icmr Study Omicron Variant
Sustained rise in antimicrobial resistance in India: ICMR study
2 years, 3 months ago

Sustained rise in antimicrobial resistance in India: ICMR study

The Hindu  

A big chunk of patients in India may no longer benefit from carbapenem, a powerful antibiotic administered mainly in ICU settings to treat pneumonia and septicemia, as they have developed antimicrobial resistance to it, an ICMR study has found. The data analysis done between January 1 and December 31, 2021, pointed towards a sustained increase in drug-resistant pathogens, resulting in …

India Bacteria Resistance Report Treat Icu Infections
Antimicrobial Resistance On the Rise in India, Immediate Corrective Measures Needed: ICMR Study
2 years, 3 months ago

Antimicrobial Resistance On the Rise in India, Immediate Corrective Measures Needed: ICMR Study

News 18  

A big chunk of patients in India may no longer benefit from carbapenem, a powerful antibiotic administered mainly in ICU settings for the treatment of pneumonia and septicemia, as they have developed antimicrobial resistance to it, an ICMR study has found. According to the ICMR report, resistance to Imipenem, which is used to treat infections caused by bacteria E coli, …

India Bacteria Resistance Report Cent Icu Infections
Delta variant major cause for COVID in children during second wave: ICMR study
2 years, 11 months ago

Delta variant major cause for COVID in children during second wave: ICMR study

Deccan Chronicle  

New Delhi: The Delta variant was the major cause of coronavirus infection in children's COVID-19 cases during the second wave in India, according to an Indian Council of Medical Research study. The most common lineages observed were Delta, followed by Kappa, Alpha and B.1.36, seen in 65.82 per cent, 9.96 per cent, 6.83 per cent and 4.68 per cent, respectively …

India Children Cent Study Delta Variant Icmr
ICMR study shows significant drop in Covid antibodies within 4 months after vaccination
3 years, 3 months ago

ICMR study shows significant drop in Covid antibodies within 4 months after vaccination

India Today  

A study on 614 fully vaccinated health workers at ICMR’s Regional Medical Research Centre in Bhubaneswar showed a significant drop in Covid antibodies within four months after complete vaccination. In this study, which was done when India witnessed a deadly delta variant surge, 308 participants were given two doses of the Covishield vaccine and 306 were given two doses of …

India Covid Study Months Vaccine Booster Doses
Delta variant infects both vaccinated, unvaccinated people in Chennai: ICMR study
3 years, 4 months ago

Delta variant infects both vaccinated, unvaccinated people in Chennai: ICMR study

Live Mint  

An Indian Council of Medical Research study conducted in Chennai has found that the Delta variant of the Covid-19 virus has the potential to infect both vaccinated and unvaccinated people, However, it added that the chances of mortality among the vaccinated group is reduced. “An ICMR study conducted in Chennai has found that the Delta variant has the potential to …

Chennai Delta Variant Vaccinated Icmr Study Vaccinated People
Covishield, Covaxin combination brings better immunogenicity than 2 doses of same vaccine: ICMR Study
3 years, 4 months ago

Covishield, Covaxin combination brings better immunogenicity than 2 doses of same vaccine: ICMR Study

The Hindu  

A study by Indian Council of Medical Research involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second in Uttar Pradesh, showed that combining these two COVID-19 vaccines elicited better immunogenicity than two doses of the same vaccine. "The findings suggest that immunisation with a combination of an adenovirus vector platform-based vaccine …

India Uttar Pradesh Vaccines Immunisation Vaccine Covaxin Covishield
Covaxin effective against Delta Plus variant of Covid-19: ICMR study
3 years, 4 months ago

Covaxin effective against Delta Plus variant of Covid-19: ICMR study

India Today  

Bharat Biotech's Covid-19 vaccine Covaxin is effective against Delta Plus variant of coronavirus, according to a study by the Indian Council of Medical and Research. "ICMR study shows #Covaxin is effective in Delta, Delta AY.1 and B.1.617.3 variants," the apex health research body said in a tweet. Covaxin, a whole-virion inactivated SARS-CoV-2 vaccine used for mass immunization in the country, …

India Study Delta Icmr Covaxin Bbv152 Icmr Study
COVAXIN Neutralises Multiple Covid-19 Variants Including Double Mutant Strain, Says ICMR Study
3 years, 8 months ago

COVAXIN Neutralises Multiple Covid-19 Variants Including Double Mutant Strain, Says ICMR Study

News 18  

An ICMR study has shown that Bharat Biotech’s COVAXIN is effective against multiple variants of SARS-CoV-2 and effectively neutralizes the double mutant of Covid-19 as well. “ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well,” ICMR said in a statement on Wednesday. Bharat Biotech has ramped up the manufacturing capacity …

Icmr Bharat Biotech Covaxin Icmr Study
Coronavirus: Plasma therapy not beneficial in reducing mortality, shows ICMR study
4 years, 3 months ago

Coronavirus: Plasma therapy not beneficial in reducing mortality, shows ICMR study

The Hindu  

Convalescent plasma therapy failed to benefit coronavirus patients, the largest trial conducted across 39 hospitals in India and spearheaded by the Indian Council of Medical Research found. The trial spanning April-July enrolled 464 hospitalised patients with “moderate” COVID-19 and administered convalescent plasma — antibodies derived from plasma filtered from the blood of those who have recovered from COVID-19 — on …

India Trial Therapy Patients Icmr Study Plasma Therapy Plasma Cp
Plasma Therapy Ineffective in Reducing COVID Mortality: ICMR Study
4 years, 3 months ago

Plasma Therapy Ineffective in Reducing COVID Mortality: ICMR Study

The Quint  

This means that at best, plasma therapy is not getting at the crux of the problem. “Here you are giving plasma for a disease which is procoagulant or prone to causing clots.” Convalescent plasma was used in certain diseases where the immune response was poor or antibodies were not produced. So if there is already lung damage due to COVID, …

Therapy Covid Plasma Icmr Study Dr Ray Plasma Therapy